Cargando…
Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis – a potential biomarker role for LysoPC
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a lethal lung disease of unknown etiology. Patients present loss of lung function, dyspnea and dry cough. Diagnosis requires compatible radiologic imaging and, in undetermined cases, invasive procedures such as bronchoscopy and surgical lung biopsy....
Autores principales: | Rindlisbacher, Barbara, Schmid, Cornelia, Geiser, Thomas, Bovet, Cédric, Funke-Chambour, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764001/ https://www.ncbi.nlm.nih.gov/pubmed/29321022 http://dx.doi.org/10.1186/s12931-018-0714-2 |
Ejemplares similares
-
LysoPC-acyl C16:0 is associated with brown adipose tissue activity in men
por: Boon, Mariëtte R., et al.
Publicado: (2017) -
LysoPC and PAF Trigger Arachidonic Acid Release by Divergent Signaling Mechanisms in Monocytes
por: Oestvang, Janne, et al.
Publicado: (2011) -
LysoPC acyltransferase/PC transacylase activities in plant plasma membrane and plasma membrane-associated endoplasmic reticulum
por: Larsson, Karin E, et al.
Publicado: (2007) -
Allosteric activation of the metabolic enzyme GPD1 inhibits bladder cancer growth via the lysoPC-PAFR-TRPV2 axis
por: Zhang, Wenlong, et al.
Publicado: (2022) -
Increasing Upstream Chromatin Long–Range Interactions May Favor Induction of Circular RNAs in LysoPC-Activated Human Aortic Endothelial Cells
por: Li, Angus, et al.
Publicado: (2019)